The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms21051852
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Adoptive Transfer of Regulatory T Cells as a Promising Immunotherapy for the Treatment of Multiple Sclerosis

Frontiers in Neuroscience
Neuroscience
2019English

Response of Letter to the Editor on Procalcitonin: A Promising Diagnostic Marker for Sepsis and Antibiotic Therapy

Journal of Intensive Care
Critical CareIntensive Care Medicine
2017English

Lateral Ventricular Cerebrospinal Fluid Diffusivity as a Potential Neuroimaging Marker of Brain Temperature in Multiple Sclerosis: A Hypothesis and Implications

Magnetic Resonance Imaging
Nuclear MedicineRadiologyBiomedical EngineeringImagingBiophysics
2015English

Argon Gas: A Potential Neuroprotectant and Promising Medical Therapy

Medical Gas Research
NeuroscienceAnesthesiologyPain Medicine
2014English

Laquinimod Therapy in Multiple Sclerosis: A Comprehensive Review

Neurology and Therapy
Neurology
2014English

Multiple Sclerosis and Aquatic Therapy. A Systematic Review

Boletin Sociedad Española Hidrologia Medica
2018English

Cytoflavin in the Complex Therapy of Multiple Sclerosis

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2018English

Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2017English

Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis

Frontiers in Neurology
Neurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy